-transparent.png){kind=logo}
In an uncontrolled study 38 patients with chronic asthma were treated for up to 4.5 years (mean 2.9) with depot injections of triamcinolone acetonide. About half had proved difficult to control on large doses of corticosteroid tablets. Three-quarters were helped and the incidence of hospital admission amongst them was reduced. Side effects were tolerable and adrenal function was only moderately depressed. Spirometry showed continuing improvement up to three years after starting triamcinolone. Whether similar improvement could have been achieved by a different dosage regimen of corticosteroid tablets or whether it might have ocurred spontaneously was not tested. A controlled trial seems warranted.
M D Peake, and
R M Cayton, and
P Howard
June 2008,
Archivos de bronconeumologia,
M D Peake, and
R M Cayton, and
P Howard
August 1996,
American journal of respiratory and critical care medicine,
M D Peake, and
R M Cayton, and
P Howard
April 1999,
Presse medicale (Paris, France : 1983),
M D Peake, and
R M Cayton, and
P Howard
August 1996,
American journal of respiratory and critical care medicine,
M D Peake, and
R M Cayton, and
P Howard
June 2009,
Thorax,
M D Peake, and
R M Cayton, and
P Howard
January 1998,
Current opinion in pulmonary medicine,
M D Peake, and
R M Cayton, and
P Howard
October 2007,
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
M D Peake, and
R M Cayton, and
P Howard
January 1976,
The Journal of allergy and clinical immunology,
M D Peake, and
R M Cayton, and
P Howard
October 2022,
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
M D Peake, and
R M Cayton, and
P Howard
February 1996,
American journal of respiratory and critical care medicine,
